These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 16334166)
1. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence. Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166 [TBL] [Abstract][Full Text] [Related]
2. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom. Han AR; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC Hepatogastroenterology; 2009; 56(93):1111-6. PubMed ID: 19760952 [TBL] [Abstract][Full Text] [Related]
3. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients. Ali SA; Amin DH; Abdelkhalek YI Jpn J Radiol; 2020 May; 38(5):472-479. PubMed ID: 32078123 [TBL] [Abstract][Full Text] [Related]
4. Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment. Cheng MF; Wu YW; Tzen KY; Huang YH; Yen RF Neoplasma; 2007; 54(4):342-7. PubMed ID: 17822325 [TBL] [Abstract][Full Text] [Related]
5. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein]. Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma. Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070 [TBL] [Abstract][Full Text] [Related]
7. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845 [TBL] [Abstract][Full Text] [Related]
8. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589 [TBL] [Abstract][Full Text] [Related]
9. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [TBL] [Abstract][Full Text] [Related]
10. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT. Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794 [TBL] [Abstract][Full Text] [Related]
12. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351 [TBL] [Abstract][Full Text] [Related]
13. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190 [TBL] [Abstract][Full Text] [Related]
15. Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study. Shin DY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ Cancer Chemother Pharmacol; 2011 Jul; 68(1):165-75. PubMed ID: 20872146 [TBL] [Abstract][Full Text] [Related]
16. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound. Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075 [TBL] [Abstract][Full Text] [Related]
17. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632 [TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein and Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439 [TBL] [Abstract][Full Text] [Related]
19. [18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein]. Shang JB; Li YH; Liu FY; Zeng QL; Wang JY; He XF; Chen Y Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):697-9. PubMed ID: 15201094 [TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. Sugiyama M; Sakahara H; Torizuka T; Kanno T; Nakamura F; Futatsubashi M; Nakamura S J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15549449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]